Shan Dong Kexing Bioproducts Co Ltd Class A 688136
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 688136 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 19.15
- Day Range
- CNY 18.70–19.18
- 52-Week Range
- CNY 10.61–22.82
- Bid/Ask
- CNY 18.98 / CNY 19.00
- Market Cap
- CNY 3.78 Bil
- Volume/Avg
- 1.2 Mil / 2.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,046
- Website
- http://www.kexing.com
Comparables
Valuation
|
Metric
|
688136
|
321550
|
301080
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 35.94 |
Price/Book Value | 2.35 | 2.92 | 1.92 |
Price/Sales | 2.88 | 34.70 | 9.11 |
Price/Cash Flow | — | — | 50.56 |
Price/Earnings
688136
321550
301080
Financial Strength
|
Metric
|
688136
|
321550
|
301080
|
|---|---|---|---|
Quick Ratio | 1.46 | 3.67 | 13.32 |
Current Ratio | 1.73 | 3.88 | 14.50 |
Interest Coverage | −2.35 | −7.20 | 32.07 |
Quick Ratio
688136
321550
301080
Profitability
|
Metric
|
688136
|
321550
|
301080
|
|---|---|---|---|
Return on Assets (Normalized) | −5.49% | −15.28% | 4.53% |
Return on Equity (Normalized) | −10.00% | −34.91% | 4.86% |
Return on Invested Capital (Normalized) | −5.12% | −17.65% | 2.83% |
Return on Assets
688136
321550
301080
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Sfppxgbmvy | Nkzqn | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qzvmfnfk | Tctyjw | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Xmwfxrlbp | Wxnfmy | $107.6 Bil | |
MRNA
| Moderna Inc | Ctmlmnpj | Kjyn | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Mgzpnfzsc | Xkxzt | $22.2 Bil | |
ARGX
| argenx SE ADR | Dngqjmb | Ynvr | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Jtmqftb | Xscyfh | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Txxsjpjnk | Ypxmwr | $15.1 Bil | |
INCY
| Incyte Corp | Zbljkzklp | Vtfcv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Dngpzxppm | Nyjvwx | $12.7 Bil |